Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine
Tina Plensäll, Maarika Liik, Artor Pogosean, Annika Eriksson, Malin Garrett, Jan Olszowy, Sven Jackmann, Anna Rostedt Punga · 2026
Read Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine by Tina Plensäll, Maarika Liik, Artor Pogosean, Annika Eriksson, Malin Garrett, Jan Olszowy, Sven Jackmann, Anna Rostedt Punga (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13324298.txt.
Description
Tina Plensäll and co-authors track long-term muscle effects of botulinum toxin care for chronic migraine, in a 2026 study. Forty women were grouped by total exposure, from treatment-naive to over five years of care. Nerve and muscle tests ran across one treatment cycle. Blood markers of nerve injury were also measured.
Migraine days fell with sustained benefit across groups in their results. Three quarters of women treated a year or more reported muscle side effects. These included drooping eyelid, double vision and shoulder weakness. Electrical tests showed denervation signs in up to sixty percent of patients. Myopathic patterns appeared in long-term users, and jitter faults were common at week twelve. Nerve injury marker levels ran higher in long-term groups.
Catalog record
| CREATOR | Tina Plensäll, Maarika Liik, Artor Pogosean, Annika Eriksson, Malin Garrett, Jan Olszowy, Sven Jackmann, Anna Rostedt Punga |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45480 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |